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Listeria monocytogenes infection generates T helper
1 (Th1) effector memory cells and CC chemokine
receptor 7 (CCR7)+ cells resembling central memory
cells. We tracked endogenous L. monocytogenes-
specific CD4+ T cells to determine how these
memory cells are formed. Two effector cell popula-
tions were already present several days after infec-
tion. One highly expressed the T-bet transcription
factor and produced Th1 memory cells in an inter-
leukin-2 (IL-2) receptor-dependent fashion. The other
resided in the T cell areas, expressed CCR7 and CXC
chemokine receptor 5 (CXCR5), and like follicular
helper cells depended on the Bcl6 transcription
factor and inducible costimulator ligand on B cells.
The CCR7+CXCR5+ effector cells produced similar
memory cells that generated diverse effector cell
populations in a secondary response. Thus, Th1
effector memory and follicular helper-like central
memory cells are produced from early effector cell
populations that diverge in response to signals
from the IL-2 receptor, Bcl6, and B cells.
INTRODUCTION
Bacterial infectiongenerally results in immunity (AhmedandGray,
1996), which is mediated by bacterial antigen-specific lympho-
cytes that proliferate and differentiate into long-lived memory
cells. In thecaseofCD4+Tcells, thisprocess involves initial prolif-
eration of naive cells with T cell antigen receptors (TCR) specific
for microbe-derived peptides bound to host major histocompat-
ibility complex II molecules (pMHCII) (Jenkins et al., 2001). The
progeny of the naive cells then differentiate into specialized
effector cells such as interferon-g (IFN-g)-producing T helper 1
(Th1) cells under the influence of cytokines such as interleukin-
12 (IL-12) produced by innate immune cells. Some effector cells
then survive after the infection is cleared to become long-lived
quiescent memory cells (Ahmed and Gray, 1996).
Memory T cells exist in at least two subsets referred to as
central memory (Tcm) and effector memory (Tem) T cells (Sal-lusto et al., 2004). Tem cells express receptors needed formigra-
tion into nonlymphoid organs and, when stimulated with the rele-
vant pMHCII ligand, immediately produce microbicidal
lymphokines (Reinhardt et al., 2001). Tcm cells express CC che-
mokine receptor 7 (CCR7) and L-selectin, which direct recircula-
tion through lymph nodes. When stimulated with the relevant
pMHCII ligand, Tcm cells do not produce microbicidal lympho-
kines immediately but proliferate to produce new effector cells,
which then acquire this function (Sallusto et al., 2004).
Th1 effectormemory (Th1em) cells arise from earlier Th1 effec-
tor cells (Harrington et al., 2008; Lo¨hning et al., 2008; Surh and
Sprent, 2008). Tem cell formation is favored by strong TCR sig-
naling (Catron et al., 2006; Sarkar et al., 2007), perhaps because
of a shift to glycolyticmetabolism (Araki et al., 2009; Pearce et al.,
2009). IL-2 receptor signaling also plays a role in Th1 effector cell
development (Khoruts et al., 1998), perhaps as a consequence
of signal transducer and activator of transcription-5 (STAT5)-
mediated upregulation of the IL-12 receptor b2-chain and the
Th1 cell-associated T-bet (Liao et al., 2011) and Blimp-1 tran-
scription factors (Gong and Malek, 2007; Pipkin et al., 2010),
which repress the Bcl6 transcription factor (Shaffer et al., 2002).
Much less is known about the formation of Tcm cells. These
cells may be the progeny of effector cells that receive weaker
TCR signals from antigen-presenting cells that display low
numbers of pMHCII ligands (Catron et al., 2006; van Faassen
et al., 2005). Recent work indicates that Tcm cells defined by
expression of CCR7 also express the B cell follicle homing
receptor CXC chemokine receptor 5 (CXCR5) (Chevalier et al.,
2011) and are potent helper cells for B cells (Chevalier et al.,
2011; MacLeod et al., 2011). Although expression of CXCR5
suggests that Tcm cells are related to follicular helper (Tfh) cells
(Morita et al., 2011), which depend on Bcl6 and provide helper
signals to germinal center B cells (Crotty, 2011), this relationship
has not been demonstrated in vivo. Here, we addressed this
issue by tracing the derivation of pMHCII-specific Tcm and
Tem cells induced during acute systemic infection with Listeria
monocytogenes (Lm).RESULTS
Detection of LLOp:I-Ab-Specific CD4+ Memory T Cells
We used a pMHCII tetramer-based approach to identify CD4+
T cells specific for two pMHCII ligands produced in C57BL/6Immunity 35, 583–595, October 28, 2011 ª2011 Elsevier Inc. 583
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Figure 1. Detection of LLOp:I-Ab-Specific CD4+ T Cells
(A) Gate used to identify CD3+ non-T cell lineage T cells (left) and CD4+ and CD8+ T cells within that population (right) from the bound fraction after enrichment
with LLOp:I-Ab+ tetramer.
(B) CD4+ T cells (left) or CD8+ T cells (right) identified as in (A) from an uninfected B6 mouse with gates on LLOp:I-Ab+ cells.
(C) CD4+ T cells from B6 mice at the indicated times after intravenous infection with Lm-2W bacteria with gates on LLOp:I-Ab+ cells. The percentages of cells
in the indicated gates are shown.
(D) Mean number (nR 3 for each data point) of CD4+ LLO:I-Ab+ T cells in the spleen and lymph nodes over the first 8 (left) or 440 (right) days after intravenous
infection with Lm-2W bacteria.
Error bars represent the standard error of the mean.
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This strain, called Lm-2W, contains a mutation in the actA
gene (Portnoy et al., 2002) and was engineered to secrete
a fusion protein containing the immunogenic 2W peptide (Rees
et al., 1999) under the control of the hly promoter (Ertelt et al.,
2009). After infection, these bacteria are taken into phagosomes
and then completely eliminated by innate and adaptive immune
mechanisms (Portnoy et al., 2002). During this process, the 2W
peptide and peptide 190-201 from listeriolysin O (LLOp) are
produced by antigen processing and bind to I-Ab MHCII mole-
cules on antigen-presenting cells. We detected CD4+ T cells
expressing TCRs specific for these ligands by staining spleen
and lymph node cells from individual mice with fluorochrome-
labeled LLOp:I-Ab or 2W:I-Ab tetramers and anti-fluorochrome
magnetic beads and by enriching the tetramer-bound cells on
a magnetized column (Moon et al., 2007). The cells that bound
to the column were stained with antibodies specific for CD3
and a mixture of non-T cell lineage-specific markers to aid in
identification of genuine CD3+ T cells (Figure 1A).
We first established the kinetics of the expansion, contraction,
and memory phases of the LLOp:I-Ab-specific CD4+ T cell
response. B6 mice that were not infected contained a small
population of LLOp:I-Ab tetramer-binding CD3+CD4+ cells in
the spleen and lymph nodes, most which were CD44lo as ex-
pected for naive cells (Figure 1B). LLOp:I-Ab tetramer-binding
cells were not detected among the MHCI-restricted CD8+
T cells in the bound fraction (Figure 1B), indicating that the584 Immunity 35, 583–595, October 28, 2011 ª2011 Elsevier Inc.CD4+ cells that bound the tetramer did so via the TCR. Naive
mice contained about 80 LLOp:I-Ab-specific CD4+ T cells, which
upregulated CD44 after intravenous injection of 107 Lm-2W
bacteria, and increased in number in the spleen and lymph
nodes beginning on day 3 to a peak of 100,000 cells by
day 7 postinfection (Figures 1C and 1D). The population then
contracted by day 20 to about 10,000 CD44hi memory cells,
which then slowly declined over the next year (Figure 1D).
Thus, LLOp:I-Ab-specific CD4+ T cells undergo the expansion,
contraction, and slowmemory decline phases exhibited by other
pMHCII-specific CD4+ T cell populations (Homann et al., 2001;
Pepper et al., 2010).
CD4+ Memory T Cell Heterogeneity
We next determined whether the LLOp:I-Ab-specific memory
cell population was heterogeneous. Naive LLOp:I-Ab-specific
cells expressed CCR7 but not T-bet or CXCR5 (Figure 2A). In
contrast, the LLOp:I-Ab-specific memory cell population in
mice infected 60 days earlier with Lm-2W bacteria consisted of
T-bethiCCR7 and T-betloCCR7+ subsets observed in a previous
study of the 2W:I-Ab-specific memory cell population (Pepper
et al., 2010). In addition, we found that the CCR7+ cells, but
not the CCR7 cells, expressed CXCR5 (Figure 2A).
We next analyzed the peak of the primary response to deter-
mine whether effector cells with the characteristics of the later
memory cells were present. PD-1 was also tested to detect
Tfh cells, which express this marker and the largest amounts
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Central and Effector Memory Cell Differentiationof CXCR5 (Crotty, 2011). As shown in Figure 2B, the LLOp:I-Ab-
specific effector cells present on day 8 after infection were split
about equally into CXCR5 and CXCR5+ populations. The
CXCR5 cells were Th1 effector cells based on expression of
large amounts of T-bet and lack of CCR7 (Figures 2B–2D). About
10% of the CXCR5+ cells were Tfh cells based on expression of
PD-1, the largest amounts of CXCR5, and the Tfh cell lineage-
defining transcription factor Bcl6 (Figures 2B and 2E). The Tfh
cells expressed more T-bet than naive cells but less than the
Th1 cells (Figures 2B and 2C). The CXCR5+ cells that lacked
PD-1 also expressed this intermediate amount of T-bet as well
as low amounts of Bcl6 (Figures 2B, 2C, and 2E). These cells ex-
pressed the most CCR7 of any of the effector cell populations
(Figures 2B and 2D). Thus, the LLOp:I-Ab-specific effector
cell population present on day 8 after infection consisted of
T-bethiCCR7 and T-betloCCR7+ subsets with the characteris-
tics of the two later memory cell populations, along with an addi-
tional Tfh cell subset. The T-bethiCCR7 cells present at the peak
of the primary response will be referred to as Th1 effector cells
and the T-betloCCR7+CXCR5+PD-1 cells as Tcm precursor
cells based on their expression of CCR7.
This analysis was repeated 60 days after infection to deter-
mine whether any of the effector populations entered the
memory pool. At this time, about half of the memory cells resem-
bled the Th1 effector cell population (Figures 2B–2E) and will
therefore be referred to as Th1em cells. The other memory cells
closely resembled the CXCR5+T-betloCCR7+ Tcm precursor
cells present on day 8, with the exception of reduced expression
of Bcl6 (Figures 2B–2E). The CXCR5+PD-1+ Tfh cell population
that was present at the peak of the response was not detected
60 days after infection (Figure 2B). A more detailed time
course experiment showed that T-bethiCXCR5 Th1 and
CXCR5+PD-1CCR7+ Tcm precursor cells peaked at day 7
and contracted to lower numbers by days 12–25 that were
maintained until day 60 (Figure 2F). In contrast, the CXCR5+
PD-1+Bcl6hi Tfh cell population peaked at day 7 but declined
progressively until disappearing by day 60 (Figure 2F). These
results suggested that some Th1 effector cells survived the
contraction phase to become Th1em cells, while some Tcm
precursor cells became Tcm cells. Tfh cells did not appear to
enter the memory cell pool.
We produced a transgenic mouse (called the r7UP mouse) to
formally test the possibility that some Tcm precursor cells
become Tcm cells. These mice contain a bacterial artificial chro-
mosome with a Cre-recombinase-estrogen receptor 2-fusion
protein sequence (Cre-ERT2) inserted between exon 3 and the
30 untranslated region of theCcr7 gene (see Figure S1A available
online). These mice also contain an enhanced yellow fluorescent
protein (eYFP) (Tsien, 1998) transgene with a floxed stop
cassette controlled by the constitutive ROSA 26 promoter (Fig-
ure S1A; Srinivas et al., 2001). Administration of tamoxifen allows
the Cre-ERT2 protein, which is normally sequestered in the
cytosol, to enter the nucleus, leading to excision of the stop
cassette (Srinivas et al., 2001) and permanent expression of
eYFP in cells that expressed CCR7 at the time of tamoxifen
treatment.
As shown in Figure S1B, about half of the CCR7+CD4+ T cells
in uninfected r7UP mice treated with tamoxifen for 5 days ex-
pressed eYFP, whereas none of the CCR7CD4+ T cells in thesemice or the CD4+ T cells in tamoxifen-treated B6mice expressed
eYFP. In addition, all the eYFP+CD44hi LLOp:I-Ab-specific cells
in r7UP mice 20 days after infection with Lm-2W on day 0 and
treatment with tamoxifen on days 16–20 expressed CXCR5 (Fig-
ure S1C). The CCR7+eYFPCD4+ T cells in tamoxifen-treated
r7UP mice were probably cells that had not yet deleted the
stop cassette upstream of the eYFP gene after 5 days of
tamoxifen treatment as observed in T cells in other Cre-ERT2
transgenic mice (Rubtsov et al., 2010). To test the capacity of
CCR7+ effector cells to become memory cells, r7UP mice were
infected with Lm-2W bacteria and labeled with tamoxifen during
the period of maximal effector cell generation from days 4 to 8
when CXCR5+PD-1 cells expressed the most CCR7 of any
CD44hi pMHCII-specific subset (Figure 2D). We focused on the
2W:I-Ab-specific population because its larger size provided
a practical advantage. About 25% of the 2W:I-Ab-specific
effector cells present on day 8 were eYFP+ (Figures 2G and
2H), and virtually all of these cells expressed CCR7 (Figures 2G
and 2I). 254 days after infection and 246 days after the cessation
of tamoxifen treatment, about 30% of the 2W:I-Ab-specific
memory cells were again eYFP+ (Figures 2G and 2H) and the
vast majority retained CCR7 (Figures 2G and 2I). Therefore,
some early CCR7+ effector cells produce stable CCR7+ Tcm
cells.
CXCR5+ Memory Cells Are Tcm Cells
Expression of CXCR5 suggested that Tcm precursor cells
might be a type of Tfh cell. If so, then Tcm precursor cells
would be located in B cell follicles. To test this possibility,
CD44hiCD4+CXCR5PD-1 Th1, CXCR5intPD-1 Tcm, and
CXCR5hiPD-1+ Tfh cells (Figure 3A) were purified by flow cyto-
metric sorting (Figure 3B) from CD45.2+ B6 mice 10 days after
infection with Lm-2W organisms and injected into naive
CD45.1+ recipients. These populations contained effector cells
specific for Lm-2W-derived pMHCII ligands and other memory
cells. One day after transfer, Th1 cells were located predomi-
nantly in the red pulp and T cell areas (identified as areas with
sparse CD4+ T cells and IgD+ B cells or dense CD4+ T cells,
respectively; Figure 3C) (Figure 3D), while Tfh cells were located
primarily in follicles (identified as areas with dense IgD+ B cells,
Figure 3C) (Figure 3D). In contrast, CXCR5+PD-1 Tcm cells
were located predominantly in the T cell areas (Figure 3D),
formally demonstrating that Tcm cells are not Tfh cells.
We also determined whether CXCR5+ memory cells behaved
like Tcm cells with respect to lymphokine production (Sallusto
et al., 2004). Mice infected with Lm-2W bacteria 92 days
earlier were injected intravenously with LLOp to restimulate
LLOp:I-Ab-specific memory cells. As shown in Figures 4A and
4B, neither the T-bethiCXCR5 Th1 nor the T-betloCXCR5+
LLOp:I-Ab-specific memory cells were producing IL-2 or IFN-g
before peptide injection. Both memory cell types retained their
preinjection patterns of T-bet and CXCR5 expression 2 hr after
LLOp challenge (Figure 4A), allowing analysis of their lymphokine
production. About 60% of the T-bet+CXCR5 Th1 memory cells
produced IFN-g and IL-2 and20%made IL-2 but not IFN-g 2 hr
after injection of LLOp (Figures 4A and 4B). In contrast, about
10% of the T-betloCXCR5+ memory cells produced IFN-g
and IL-2 whereas 60% made IL-2 but not IFN-g. Therefore,
the LLOp:I-Ab-specific CXCR5+ memory cells are less potentImmunity 35, 583–595, October 28, 2011 ª2011 Elsevier Inc. 585
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Figure 2. Identification of Tem and Tcm Cells
(A) Plots of CCR7 versus T-bet (left) or CXCR5 (right) on LLOp:I-Ab-specific CD44lo naive cells from uninfected B6 mice (red dots) or LLOp:I-Ab-specific CD44hi
memory cells from mice infected with Lm-2W bacteria 60 days before analysis (black contours).
(B) Plots of CXCR5 versus PD-1 used to identify CXCR5PD-1 Th1 cells, CXCR5intPD-1 Tcm cells, and CXCR5hiPD-1+ Tfh cells on days 8 or 60 after intra-
venous infection with Lm-2W bacteria, with histograms of T-bet, CCR7, and Bcl6 on Th1 cells (black line), Tcm cells (gray line), Tfh cells (dashed line), or CD44lo
naive cells (shaded histogram).
(C–E) Mean fluorescence intensities (MFI) of T-bet (C), CCR7 (D), and Bcl6 (E) on the indicated cell types from three individual mice on days 8 (filled circles) or 60
(open circles) after intravenous infection with Lm-2W bacteria.
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Figure 3. Tcm Precursor Cells Are Located in the T Cell Areas
(A) Gates used to sort purify the indicated subsets from the spleen and lymph nodes of B6 mice 10 days after Lm-2W infection. CCR7 staining was also used as
a sorting parameter (not shown) with Th1 cells sorted as CCR7 cells, Tcm cells as CCR7+ cells, and Tfh cells as CCR7lo cells.
(B) Postsort analysis of the indicated populations. 4 3 106 Th1, 3 3 106 Tcm, or 106 Tfh cells were transferred into CD45.1+ recipients.
(C) CD4 (green), IgD (purple), and CD45.2 (red) expression in a spleen section from a naive B6mouse that received Tcm cells 1 day before analysis. CD45.2+ cells
that were also CD4+ appeared orange. A T cell area (T), follicle (F), and red pulp area (RP) are indicated. Three CD4+CD45.2+ transferred T cells in the T cell area
and one in the follicle are labeled with asterisks.
(D) Percentage of Th1 (151 cells), Tcm precursor (91 cells), and Tfh (38 cells) cells located in the indicated areas 1 day after transfer.
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expected for Tcm cells.
Finally, we used an adoptive transfer approach to test
whether CXCR5+ memory cells produced diverse effector cell
progeny during the secondary response. CD44hiCD4+CXCR5+
CCR7+ (containing 2W:I-Ab-specific Tcm cells) and CD44hiCD4+
CXCR5CCR7 (containing 2W:I-Ab-specific Th1em cells) cells
were sorted from B6 mice 40 days after infection with Lm-2W
organisms and injected into naive CD45.1+ recipients. The recip-
ient mice were then challenged with Lm-2W organisms, and the
phenotype of the donor and recipient 2W:I-Ab-specific T cells
(Figure 4C) was assessed 6 days later. As shown in Figures 4C
and 4D, 96% of the effector cell progeny of CCR7CXCR5
Th1em cells were Th1 cells. In contrast, the progeny of CXCR5+
memory cells consisted of 70% Th1 cells, 21% Tcm precursor
cells, and 5% Tfh cells, whereas the naive cells of the recipients
produced 44% Th1 cells, 43% Tcm precursor cells, and 8%
Tfh cells. Therefore, although CXCR5+ memory cells have
a tendency to produce Th1 effector cells, they are more efficient
than Tem cells at generating Tcm precursor cells and Tfh cells.
Development of Th1em and Tcm Cells
The results were consistent with the possibility that Th1 effector
and Tcm precursor cells generated early in the primary response(F) Mean number (nR 3) of LLO:I-Ab-specific Th1 (filled circles), Tcm (open circl
Error bars represent the standard error of the mean.
(G) CCR7 and eYFP expression by 2W:I-Ab-specific CD4+ T cells in 2W:I-Ab tetra
with tamoxifen on days 4–8 postinfection, and analyzed on days 8 or 254 postin
(H and I) Percentage of eYFP+ cells among 2W:I-Ab-specific cells (H) or CCR7+ c
See also Figure S1.gave rise to Th1em and Tcm cells. We examined very early times
after Lm-2W infection to get insight into the origins of these
populations. The IL-2 receptor alpha chain (CD25) was included
in the analysis because it has been implicated in Th1 cell devel-
opment in other systems (Khoruts et al., 1998; Liao et al., 2011).
Naive LLOp:I-Ab-specific cells in uninfected mice did not
express CXCR5 or CD25 (Figure 5A). Remarkably, the LLOp:I-
Ab-specific population had already split equally into CXCR5
and CXCR5+ subsets only 3 days after infection (Figure 5A)
when expansion of LLOp:I-Ab-specific T cells was first detected
(Figure 1D). Notably, most of the CXCR5 cells also expressed
CD25 and most of the CXCR5+ cells did not (Figure 5A). On
day 4 after infection, the CXCR5 cells expressed more T-bet
than CXCR5+ cells (Figure 5B).
These findings raised the possibility that CD25 was required
for the development of the CXCR5 Th1 effector cells. This
premise was tested in chimeras containing a mixture of wild-
type and CD25-deficient T cells so that both populations
could be monitored under conditions where normal regulatory
T cells were present to prevent the autoimmunity that occurs in
intact CD25-deficient mice (Willerford et al., 1995). As shown in
Figures 5C and 5D, CD25-deficient LLOp:I-Ab-specific naive
cells were about one tenth as good as wild-type cells at gener-
ating T-bethiCXCR5 Th1 cells in these chimeras 5 days afteres), or Tfh (gray circles) cells identified as shown in (B).
mer-enriched samples from r7UP mice infected with Lm-2W bacteria, treated
fection.
ells among eYFP+ 2W:I-Ab-specific cells (I) from individual mice.
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Figure 4. Secondary Responses by Memory Cells
(A) Contour plots showing T-bet and CXCR5 expression by LLOp:I-Ab-specific T cells (left) or intracellular IFN-g and IL-2 staining (bottom) in LLOp:I-Ab-specific
Tem cells (middle) or Tcm cells (right) from day 92 Lm-2W-infected mice before (top) or 2 hr after (bottom) intravenous injection of LLOp.
(B) Percentage of LLOp:I-Ab-specific Tcm or Tem cells producing the indicated lymphokines before (filled circles) or 2 hr after (open circles) intravenous injection
of LLOp. **p < 0.01.
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Central and Effector Memory Cell DifferentiationLm-2W infection but were as good as wild-type cells at gener-
ating CXCR5+PD-1 Tcm precursor cells and CXCR5+PD-1+
Tfh cells. CD25 is therefore required for the optimal development
of T-bethiCXCR5 Th1 cells but not the other effector cell
populations.
We also examined the role of Bcl6 in the development of
Tcm cells. Bcl6 was expressed in higher amounts in the
CXCR5+ subset of LLOp:I-Ab-specific cells 3 days after Lm-2W
infection than in the CXCR5 subset (Figure 6A). Radiation
bone marrow chimeras containing a mixture of wild-type and
Bcl6/ (Dent et al., 1997) cells were used to test whether Bcl6
was required for the formation of CXCR5+ T cells. Indeed,
Bcl6-deficient CD4+ T cells failed to generate early LLOp:I-Ab-
specific CXCR5+ cells on day 3 (Figures 6A and 6B). Similarly,
CXCR5+PD-1 Tcm precursor cells and CXCR5+PD-1+ Tfh cells
were generated at only 1% of the amount generated from wild-
type CD4+ T cells 7 days after Lm-2W infection (Figures 6C
and 6D). The Bcl6-deficient LLOp:I-Ab-specific T cells present
on day 7 were all T-bethi, indicating that T-betlo Tcm cell precur-
sors were truly absent and had not simply lost CXCR5 (Fig-
ure 6C). We also produced radiation bone marrow chimeras
containing a mixture of wild-type and Bcl6+/ T cells to test the
dependence of the two types of CXCR5+ effector cells on the
amount of Bcl6 expressed. As shown in Figure 6D, LLOp:I-Ab-
specific Bcl6+/ Tcm precursor cells formed only slightly less
well than wild-type cells 7 days after Lm-2W infection, whereas
Bcl6+/ Tfh cells were generated at 10% of the amount gener-
ated from wild-type T cells. These results demonstrate that
Tcm precursor cells and Tfh cells both depend on Bcl6 although
Tcm precursor cells are less dependent.
ICOS Signals from B Cells Sustain Tcm Cell
Differentiation
The Bcl6 requirement of Tcm precursor cells and Tfh cells
prompted us to determine whether Tcm precursor cells also
required signals from B cells and the ICOS costimulatory
receptor (Akiba et al., 2005; Vinuesa et al., 2005) as described
for Tfh cells (Nurieva et al., 2008). 7 and 25 days after Lm-2W
infection, LLOp:I-Ab-specific Tcm precursor cells and Tfh cells
were produced in mMT mice lacking B cells (Kitamura et al.,
1991) at about 10% of the number produced in wild-type mice
(Figure 7A). Therefore, B cells are necessary for optimal genera-
tion of Tcm and Tfh cells.
The role of ICOS was tested in bone marrow chimeras recon-
stituted with an equal mixture of ICOS-deficient (Tafuri et al.,
2001) and wild-type bone marrow cells so that ICOS-deficient
T cells could be analyzed under conditions where wild-type
T cells were present to promote a normal germinal center
response. ICOS-deficient and wild-type Th1 effector cells
were generated equally well 7 days after Lm-2W infection and
maintained as Th1em cells on day 20 (Figure 7B). In contrast,
ICOS-deficient Tcm cell precursors were generated at about
30% of the amount on day 7 and survived as Tcm cells on day(C) 4.8 3 105 CD44hiCD4+CCR7+CXCR5+PD-1 Tcm or 4.3 3 105 CD44hiCD4+
30 days earlier with Lm-2W bacteria and transferred into CD45.1+ mice, which we
donor (upper gates, left) or recipient (lower gates, left) 2W:I-Ab-specific cells 6 da
identify Th1 effector, Tcm precursor, and Tfh cells of donor (middle) or recipient
(D) Percentage of Th1 effector, Tcm precursor, or Tfh cell progeny from donor T20 at about 3% of the amount generated from the comparable
wild-type populations. Tfh cells were even more dependent on
ICOS, forming from ICOS-deficient cells at about 1% of the
amount formed from wild-type cells on days 7 and 20 after
infection.
We next determined whether B cells were the critical source of
ICOSL. Chimeras were made by reconstituting lethally irradiated
B6 mice with an equal mixture of ICOSL-deficient (Mak et al.,
2003) and wild-type or mMT bone marrow cells incapable of
forming B cells (Kitamura et al., 1991). All of the B cells in the
chimeras made with wild-type bone marrow expressed ICOSL,
and all of the B cells in the chimeras made with ICOSL-deficient
bone marrow cells lacked ICOSL, while half of the dendritic cells
in those chimeras expressed ICOSL. 7 or 8 days after Lm-2W
infection, the number of LLOp:I-Ab-specific Tcm precursor cells
was slightly but not significantly lower in chimeras containing
ICOSL-deficient B cells than in chimeras containing wild-type
B cells (Figure 7C). However, by day 20, the number of LLOp:I-
Ab-specific Tcm cells formed in chimeras containing ICOSL-
deficient B cells was only 1% of the number formed in chimeras
containing wild-type B cells (Figure 7C). The number of Tfh cells
generated in chimeras containing ICOSL-deficient B cells was
also only 1% of the number formed in chimeras containing
wild-type B cells. The formation of Tcm cells and Tfh cells in
chimeras lacking ICOSL on B cells therefore mirrored the
production of these populations from ICOS-deficient T cells.
Together, these experiments demonstrate that the interaction
of ICOS on the T cells with ICOSL on B cells is necessary for
optimal generation of Tfh cells and themaintenance of Tcm cells.
DISCUSSION
Our results demonstrate that pMHCII-specific T-bethiCXCR5
and T-betloCXCR5+CD4+ T cells were already present at the
peak of the primary response to a vaccine strain of Lm. Several
observations indicate that some of these effector cells survived
the contraction phase to become Th1em and Tcm cells. First,
the two memory cell populations that survived the contraction
phase had phenotypes that were very similar to the two effector
cell populations with the exception that T-betloCXCR5+ memory
cells lacked Bcl6. Second, several other groups have demon-
strated that memory cells can be derived from IFN-g-producing
Th1 effector cells (Harrington et al., 2008; Lo¨hning et al., 2008).
Third, our studies of the r7UP mouse revealed that CCR7+ Tcm
cells were derived from CCR7+ effector cells present at the
peak of clonal expansion. Our results indicate that Tfh cells fail
to enter the memory cell pool although we cannot rule out the
possibility that small numbers of these cells lose expression of
PD-1 and make a minor contribution to the CXCR5+ memory
cell population.
The bifurcation of Lm pMHCII-specific effector cells into
CXCR5 and CXCR5+ subsets was already apparent at the
time of the earliest proliferation at day 3 as recently describedCCR7CXCR5PD-1 Tem cells were sorted from CD45.2+ B6 mice infected
re then challenged with Lm-2W bacteria. Representative plots used to identify
ys after challenge are shown, along with plots of PD-1 versus CXCR5 used to
(right) origin.
em, donor Tcm, or recipient naive cells. **p < 0.01.
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Figure 5. Development of Th1 Effector Cells
Depends on CD25
(A) Dot plot of CD25 versus CXCR5 expression by
LLOp:I-Ab-specific cells from naive mice (red dots)
or frommice 3 days after intravenous infection with
Lm-2W bacteria (black dots). The values on the
plots represent the percentage of cells in the
indicated quadrants from naive (red) or Lm-2W-
infected (black) mice. The scatter plot shows the
percentage of CD25+ total naive CD4+ T cells from
uninfected B6 mice (diamonds) or CXCR5 (filled
circles) or CXCR5+ (open circles) LLOp:I-Ab-
specific cells from mice 3 days after intravenous
infection with Lm-2W bacteria. ***p < 0.001.
(B) T-bet expression in total naive CD4+ T cells from
uninfected B6 mice (shaded) or CXCR5 (black) or
CXCR5+ (gray) LLOp:I-Ab-specific cells from mice
4 days after intravenous infection with Lm-2W
bacteria, with a scatter plot showing the fold in-
crease of T-betmean fluorescence intensity (MFI) of
the indicated LLOp:I-Ab-specific populations over
the T-bet MFI of naive CD4+ T cells. ***p < 0.001.
(C) Plots of CD45.1 versus CD45.2 expression
and CD44 expression versus LLOp:I-Ab tetramer
staining of CD4+ T cells in a tetramer-enriched
sample from a radiation chimera produced with
CD45.2+ wild-type and CD45.1+CD45.2+ Il2ra/
bone marrow, 5 days after intravenous infection
with Lm-2W bacteria.
(D) Number of LLOp:I-Ab-specific Th1, Tcm, and
Tfh cells identified as in Figure 2B of wild-type
(filled circles) or Il2ra/ (open circles) origin from
individual mice, 5 days after intravenous infection
with Lm-2W bacteria. **p < 0.01.
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Central and Effector Memory Cell Differentiationin another CD4+ T cell response (Choi et al., 2011). Although it
is not clear what caused this early bifurcation, an asymmetric
division of a CD25+ mother cell into CD25+ and CD25 daughter
cells is a possibility (Chang et al., 2007). Once this split occurred,
then work by others suggests a scenario in which IL-2 receptor
signaling in the CD25+ cells activates STAT5 (Hou et al., 1995;
Lin et al., 1995), which induces the IL-12 receptor and T-bet
(Liao et al., 2011) and suppresses Bcl6 and CXCR5 by inducing
Blimp-1 (Choi et al., 2011; Gong and Malek, 2007; Shaffer et al.,
2000). This sequence of events would be predicted to cause590 Immunity 35, 583–595, October 28, 2011 ª2011 Elsevier Inc.the early CD25+CXCR5 cells to retain
T-bet and differentiate into Th1 effector
cells, a fraction of which then survive as
Th1em cells.
Conversely, the lack of IL-2 receptor
signaling in the early CD25 cells may
have been conducive to Bcl6 expression,
which we found was essential for forma-
tion of early CXCR5+ effector cells and
subsequent PD-1 Tcm precursor and
PD-1+ Tfh cell progeny. Although it is
not clear what drives the split between
PD-1 Tcm precursors and PD-1+ Tfh
cells, our finding that Tfh cells require
more Bcl6 and earlier ICOS signals than
Tcm precursor cells may be a clue. Tfhcells tend to express TCRs with higher affinity for pMHCII ligands
than other cells in the population (Fazilleau et al., 2009). The
formation of these cells is also promoted by additional pMHCII
presentation by B cells (Deenick et al., 2010; Johnston et al.,
2009). Therefore, early CXCR5+ effector cells that receive very
strong TCR and ICOS signals may express and maintain the
large amounts of Bcl6 needed to commit to the Tfh fate. Other
early CXCR5+ effector cells that receive less strong TCR and
ICOS signals may express enough Bcl6 to become Tcm cells
but not enough to maintain Bcl6 and become Tfh cells.
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Figure 6. Development of Tcm Cells Depends on Bcl6
(A) Plot of Bcl6 versus CXCR5 expression by wild-type (black dots) or Bcl6/ (red dots) LLOp:I-Ab-specific cells from a wild-type plus Bcl6/ mixed radiation
bone marrow chimera 3 days after intravenous infection with Lm-2W bacteria with a scatter plot showing the percentage of Bcl6+ naive CD4+ T cells from
uninfected B6 mice (diamonds) or CXCR5 (filled circles) or CXCR5+ (open circles) LLOp:I-Ab-specific cells from wild-type mice 3 days after infection.
(B) Number of wild-type (filled circles) or Bcl6/ (open circles) CXCR5 or CXCR5+ LLOp:I-Ab-specific cells from three wild-type plus Bcl6/ mixed radiation
bone marrow chimeras, 3 days after intravenous infection with Lm-2W bacteria. *p < 0.05.
(C) Plots of CXCR5 versus PD-1 staining used to identify wild-type or Bcl6/ LLOp:I-Ab-specific Th1 effector cells, Tcm precursor cells, and Tfh cells from
wild-type plus Bcl6/ mixed radiation bone marrow chimeras 7 days after Lm-2W infection. T-bet expression by wild-type or Bcl6/ LLOp:I-Ab-specific cells
in these chimeras is also shown.
(D) Number of LLOp:I-Ab-specific Th1, Tcm, and Tfh cells identified as in (C) from individual wild-type plus Bcl6/ (left) or wild-type plus Bcl6+/ (right) mixed
radiation bone marrow chimeras, 7 days after intravenous infection with Lm-2W bacteria. *p < 0.05, ***p < 0.001.
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Central and Effector Memory Cell DifferentiationAlthough Tcm and Tfh cells express CXCR5 and depend on
Bcl6, our results show that these are different cells. For example,
Tcm cells were located in the T cell areas, not in the follicles like
Tfh cells. In addition, we found that Tcm cells did not expressBcl6 and were relatively inefficient at producing Tfh cells during
the secondary response. Indeed, Th1 effector cells were the
dominant progeny produced by Tcm cells when exposed to
antigen. These properties may be related to the fact that TcmImmunity 35, 583–595, October 28, 2011 ª2011 Elsevier Inc. 591
B100
101
102
103
104
105
106
100
101
102
103
104
105
106
100
101
102
103
104
105
106
Wild-type
Icos-/-
Wild-type
B cells
Icosl-/- 
B cells
A 
Lm-2W, Day 7 Lm-2W, Day 20
Lm-2W, Day 20Lm-2W, Day 7 or 8
LL
O
p:
I-A
b+
 T
 c
el
ls **
***
100
101
102
103
104
105
106
***
C 
Lm-2W, Day 25Lm-2W, Day 7
100
101
102
103
104
105
106
* * Wild-type
μMT
100
101
102
103
104
105
106
***
**
Th1
cells
Tcm
cells
Tfh
cells
Th1
cells
Tcm
cells
Tfh
cells
Th1
cells
Tcm
cells
Tfh
cells
Th1
cells
Tcm
cells
Tfh
cells
Th1
cells
Tcm
cells
Tfh
cells
Th1
cells
Tcm
cells
Tfh
cells
LL
O
p:
I-A
b+
 T
 c
el
ls
LL
O
p:
I-A
b+
 T
 c
el
ls
Figure 7. Development of Tcm Cells Depends on ICOS Signals from B Cells
Number of LLOp:I-Ab-specific Th1, Tcm, and Tfh cells identified as in Figure 2B from individual (A) wild-type or B cell-deficient mMT mice, (B) wild-type
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after intravenous infection with Lm-2W bacteria. *p < 0.05, **p < 0.01, ***p < 0.001.
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Central and Effector Memory Cell Differentiationcells expressed low amounts of T-bet at the time of challenge,
and thus were partially committed to the Th1 cell lineage.
Notably, however, Tcm cells produced some CXCR5+ effector
cells, indicating that they were more flexible than Th1em cells,
which produced only Th1 effector cells. The reports that
CXCR5+Bcl6 Tcm-like memory cells present in humans
(Chevalier et al., 2011) and similar cells in mice immunized with
soluble antigen (MacLeod et al., 2011) or Salmonella infection
(Lee et al., 2011) are potent helpers of B cell proliferation and
antibody production is further evidence of the polyfunctionality
of Tcm cells.
An implication of this work is that B cells enhance the produc-
tion of Tcm cells, adding to other studies showing a role for
B cells in memory T cell formation (Linton et al., 2000; Whitmire
et al., 2009). In our study, it was very likely that many B cells in
the spleen had access to Lm bacteria soon after intravenous592 Immunity 35, 583–595, October 28, 2011 ª2011 Elsevier Inc.injection. It will be of interest to determine whether Tcm cells
fail to form during intracellular infections where B cells have
less access to bacteria.
EXPERIMENTAL PROCEDURES
Mice
Six- to eight-week-old C57BL/6 (B6), 129x1/SvJ, B6.129S2-Ighmtm1Cgn/J
(mMT) (Kitamura et al., 1991), B6.129P2-Icostm1Mak/J (ICOS-deficient) (Tafuri
et al., 2001), B6.129P2-Icosltm1Mak/J (ICOSL-deficient) (Mak et al., 2003),
and B6.SJL-Ptprca Pep3b/BoyJ (CD45.1) mice were from the Jackson Labora-
tory or the National Cancer Institute. B6.129S6-Bcl6 mice (Bcl6-deficient)
(Dent et al., 1997) were obtained from M. Mescher (University of Minnesota).
Foxp3-GFP Cd25/CD45.1+CD45.2+ mice were obtained from D. Campbell
(University of Washington). All mice were housed in specific-pathogen-free
conditions in accordance with guidelines of the University of Minnesota
and National Institutes of Health. The Institutional Animal Care and Use
Committee of the University of Minnesota approved all animal experiments.
Immunity
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P. Chambon (IGBMC) provided the Cre-ERT2 plasmid. Recombination of the
Cre-ERT2 coding sequence into the 30-untranslated region (UTR) of CCR7 in
bacterial artificial chromosome clone RP23-80024 (Invitrogen, Carlsbad, CA)
was performed as described (Kaplan et al., 2005). Primers used for generation
of the recombination cassette were: 50 A box, 50-TTAAGGCGCGCCGCTC
CTATGCATCAGCATTGA-30; 30 A box, 50-GGCGGATCCCGGATGTGTGCA
CCACATTAAGGCTC-30; 50 B box, 50-GCCACAGCTTGAGCACAGACTCTC
CATCCACCGAA-30; 30 B box, 50-TATTAAGGCCGGCCCTGCAGGTGTATGTG
CAAGAC-30; 50 I box, 50-GGTGCACACATCCGGGATCCGCCCCTCTCC-30;
30 I box, 50-AGAGTCTGTGCTCAAGCTGTGGCAGGGAAACCCTC-30. The re-
combined construct was injected into the pronuclei of B6mice in the University
of MinnesotaMouse Genetics Laboratory. Transgenic mice were then crossed
to the B6;129Gt(ROSA)26Sortm2Sho/J strain. eYFP expression was induced
by daily intraperitoneal injection of tamoxifen (0.05 mg/g) for 5 days.
Bone Marrow Irradiation Chimeras
Bone marrow cells were harvested from femurs, tibias, and humeri. T cells
were depleted from bone marrow cell suspensions with anti-Thy1.2 (30-H12,
Bio X Cell) and low-toxicity rabbit complement (Cedarlane Laboratories). In
some cases, CD45.1+CD45.2+ wild-type bone marrow cells were mixed with
an equal number of CD45.2+Icos/, Bcl6/, or Bcl6+/ bone marrow cells.
5–10 3 106 total bone marrow cells were injected into lethally irradiated
(1,000 rads) CD45.1+ mice. In other cases, CD45.2+ wild-type bone marrow
cells were mixed with an equal number of CD45.1+CD45.2+Il2ra/ bone
marrow cells and injected into lethally irradiated (1,000 rads) CD45.1+ mice.
In other cases, wild-type or Icosl/ bone marrow cells were mixed with an
equal number of mMT bone marrow cells and 5–10 3 106 total bone marrow
cells were injected into lethally irradiated (1,000 rads) mMT mice. Variations
in the absolute numbers of tetramer-binding T cells because of slight differ-
ences in chimerism were corrected with the following formula: c = (r / p) 3
50%, where p is the percent of cells among donor-derived cells obtained
experimentally, r is the absolute number of tetramer-binding T cells obtained
experimentally, and c is the absolute number after the correction.
Infections
Mice were injected intravenously with 107 actA-deficient Lm bacteria engi-
neered to secrete a fusion protein containing an immunogenic peptide called
2W (Lm-2W) (Ertelt et al., 2009).
Tetramer Production
Biotin-labeled soluble I-Ab molecules containing 2W peptide (EAWGALAN
WAVDSA) covalently attached to the I-Ab beta chain were produced in
Drosophila melanogaster S2 cells, then purified and made into tetramers
with streptavidin-phycoerythrin or streptavidin-allophycocyanin (Prozyme) as
described (Moon et al., 2007). Biotin-labeled soluble I-Abmolecules containing
LLO190-201 (NEKYAQAYPNVS, LLOp) were made in a similar fashion except
that the I-Ab alpha chain contained a cysteine substitution at position 72, which
allowed a disulfide bond to form between this cysteine and the cysteine 2 resi-
dues after the LLOp, in effect locking the peptide into the correct binding
register (Stadinski et al., 2010).
Cell Enrichment and Flow Cytometry
All antibodies were from eBioscience unless noted. Spleen and lymph node
cells were prepared and then were stained for 1 hr at room temperature with
LLOp:I-Ab- or 2W:I-Ab-streptavidin-allophycocyanin tetramers and 2 mg
each of peridinin chlorophyll protein-cyanine 5.5-conjugated antibody to
CCR7 (anti-CCR7; 4B12) and phycoerythrin-conjugated antibody to CXCR5
(2G8; Becton Dickinson). Samples were then enriched for bead-bound cells
on magnetized columns and a portion was removed for counting as described
(Moon et al., 2007). For identification of surface phenotype, the rest of the
sample underwent surface staining on ice with a mixture of antibodies specific
for B220 (RA3-6B2), CD11b (MI-70), CD11c (N418), CD8a (5H10; Caltag), PD-1
(J43), CD4 (RM4-5), CD3ε (145-2C11), CD25 (PC61.5), CD44 (IM7), CD45.1
(A20), and/or CD45.2 (104), each conjugated with a different fluorochrome.
In experiments designed to detect transcription factors, the cells were surface
stained with some of the aforementioned antibodies, then treated with Foxp3
Fixation/Permeabilization Concentrate and Diluent (eBioscience) and stainedfor 1 hr on ice with antibodies against T-bet (4B10; Biolegend) and/or Bcl6
(K112-91; Becton Dickinson). In experiments designed to detect cytokines,
the cells were surface stained, then treated with BD Cytofix/Cytoperm (Becton
Dickinson) overnight and stained for 1 hr on ice with antibodies against IL-2
(JES6-5H4) and IFN-g (XMG1.2) in Perm Wash solution (Becton Dickinson).
In all cases, cells were then analyzed on an LSR II or Fortessa (Becton Dickin-
son) flow cytometer. Data were analyzed with FlowJo software (TreeStar).
Lymphokine Production
Mice were infected intravenously with Lm-2W bacteria. 92 days later, the mice
were injected intravenously with 100 mg of LLOp. Spleen and lymph nodes
were analyzed for the presence of intracellular IL-2 and IFN-g in LLOp:I-Ab-
specific T cells as described previously (Pepper et al., 2010).
Cell Transfer
Flow cytometric sorting was used to purify T cell populations before adoptive
transfer. For analysis of memory cell function in the secondary response,
spleens and lymph nodes were collected from B6 mice infected intrave-
nously at least 20 days earlier with Lm-2W bacteria and stained with
fluorochrome-labeled antibodies to CD4, CD44, CCR7, PD-1, and CXCR5.
CD44hiCXCR5CCR7CD4+ Th1em cells and CD44hiCXCR5+CCR7+ Tcm
cells were then sorted with a FACSAria (Becton Dickinson) flow cytometer.
Sorted cells were then injected intravenously into CD45.1+ recipients, which
were then infected intravenously with 107 Lm-2W bacteria. Six days later, the
phenotype of 2W:I-Ab-specific T cells was determined after tetramer-based
cell enrichment as described above.
For analysis of Tcm cell location, B6 mice were infected intravenously with
Lm-2W bacteria. Eight days later, spleen and lymph node cells from these
mice were stained with fluorochrome-labeled antibodies against CD4, CD44,
CXCR5, CCR7, and PD-1. CD4+CD44loCXCR5CCR7PD-1 Th1 cells,
CXCR5intCCR7hiPD-1 Tcm cells, and CXCR5hiCCR7loPD-1+ Tfh cells were
then sorted and transferred into CD45.1+ recipients. 7 mm spleen sections
were prepared as previously described (Pape et al., 2007) and stained with
fluorescein isothiocyanate-anti-IgD (11-26; eBioscience), biotin-anti-CD4
(GK1.5; eBioscience), and allophycocyanin-anti-CD45.2 (104; eBioscience,
followed by Cy3-streptavidin (Invitrogen). Stained sections were imaged as
previously described (Pape et al., 2007) with a Leica DM5500B automated
upright microscope and a Leica DFC340FX Digital Camera.
Statistical Analysis
Differences between two data sets were analyzed by a paired or unpaired
two-tailed Student’s t test with Prism (Graphpad) software.SUPPLEMENTAL INFORMATION
Supplemental Information includes one figure and can be found with this
article online at doi:10.1016/j.immuni.2011.09.009.
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